US 8212052
Dual-acting benzoimidazole antihypertensive agents
granted A61PA61P29/00A61P3/06
Quick answer
US patent 8212052 (Dual-acting benzoimidazole antihypertensive agents) held by Theravance, Inc. expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P29/00, A61P3/06, A61P3/10, A61P43/00